InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,288.80
(
-0.62%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.92
(
-0.11%
)
Bitcoin
64,598.57
(
-0.34%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jaybe

Send PM Follow Ignore
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

jaybe

Re: bellweather1 post# 178025

Friday, 05/16/2014 3:18:38 PM

Friday, May 16, 2014 3:18:38 PM

Post# of 252279
That's nodal response, as in lymphocyte count, which is a secondary measure of activity in CLL. ORR is always less than nodal response, as in ibrutinib had 100% nodal with 66% ORR, and IPI-145 had 84% nodal with 47% ORR. So if TG-1202 can go from 67% nodal to 85% ORR then its a breakthrough.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up